Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
HLTT/QMEI...additional developments......
HLTT(.275): Sales of the wound care product (Amniobind) began in the month of September, with the company recording $776K in revenue. The Q3 filed last week contains this somewhat interesting statement......
Happy Thanksgiving to one and all
Deng Flutie it is lol
Shouldn't that be Deng Flutie lol?
I see Doug Flutie on the horizon
What he needs is a miracle, imho!
$30 mil mkt cap at a $1 is still low - he needs an eye opener here
Some folks lack that killer instinct to pounce, when opportunity knocks.
He had at least 10 different occasions since 2014 to do a deal that would have really sent it, during very exuberant markets imho..
At this point, whomever posted that a run to .25 with a subsequent dump down to .05 is the odds on favorite to be correct, imho.
Avoiding CE after 3/23 is critical right now - great target firm can still send it but yeah he did screw this thing up
Yup, so much for my $4.59 delusional price targets on askh
He waited tooooooooooooooooo long, assuming anything actually gets done!
HOOD lod $8.75 buy buy buy
Great contributions and insight to this board, my good man.
STJO/LFLS...added to positions......
STJO(.104): Picked up some more shares today, following the updates to the OTC Markets profile page. Management seems to be picking up the pace a little bit with regards to getting things updated. Legacy share valuation is under $1.4M at the current price. Just have a feeling this is going to move nicely at some point.
LFLS(.0799): Picked up some more shares of LFLS today. Currently averaged in under 5.6 cents per share. I first noticed it when Traderfan mentioned it over on Twitter after LFLS issued a press release on November 1. I'm somewhat surprised this stock has not been getting more attention. Unless I am really off on my analysis, this potential shell looks extremely attractive on a structural/fundamental basis.
Based on my understanding/interpretation of the press release, it looks like the CEO/insiders intend to sell more than 48M of their existing shares to a RM candidate. That would leave a legacy share count of less than 10M shares. Assuming there are no overly negative changes to that plan, LFLS certainly looks like a very compelling investment at these sub-.10 levels.
I added some shares today after noticing the float update yesterday showed an increase of around 3.2M shares. This is purely a guess on my part (after looking at the management/insider ownership table in the last quarterly report), but that float update suggests to me the possibility that the 621K investment club shares may have been distributed and two of the directors ( Daniela Haynie and Marc Phelps) may have been removed. Combined, the investment club shares and the director positions are roughly 3.2M shares.
HOOD lod $9.53 buy buy buy
HOOD lod $8.50 buy buy buy
TPIA .18 Colorado vote to legalize mushrooms
TPIA has SEC filing to merger stock on NASDAQ at price of $1.56
Current price $0.18
Float only 1m
https://www.otcmarkets.com/stock/tpia/security
DBMM 34% gain Fri, on 4 million shares of volume. That has got to be extra-scary for naked shorts if we see a mega-short-squeeze develop!
IHT merger just discovered!
Check out the DD. Pieced together what is happening and people starting to find it the past couple days.
$IHT DD thread
— J0L (@JolTrades) November 4, 2022
IHT owns and manages hotels, they’re profitable, high insider ownership, share buyback program, and best of all…newly discovered plans for what looks like a MERGER with UniGen. See below… pic.twitter.com/OUBlajtNPm
QMEI...additional information related to Esther's departure......
EVCI..STJO..TCRI...added to positions recently.....
EVCI(.22): Picked up more shares of the EVCI shell at prices around the 21-25 cent level. I consider EVCI and BDCM (which I also own) to be the most attractive Synergy Management shells from an overall structure/valuation standpoint.
STJO(.0505): Picked up a few more shares of STJO at 4.5 cents. Yesterday's quarterly filing appears to provide the first confirmation that the 86.5M shares have been issued and the RPM merger has been completed.
Lack of timely updates/transparency on the merger probably contributed to the pullback under ten cents. Depending on what additional information/details materialize here, I think STJO would have the ingredients for a significant move upward. Medical devices, healthcare industry, and a legacy share valuation that is currently under $700K.
TCRI(.05): Picked up more shares of the TCRI shell under the 6-cent level. Q3 report should get filed in around 2 weeks or so, and it will be interesting to see if there are any updates or material information.
Investor interest in TCRI fell off a cliff when Munaf Ali disclosed that they had decided not to bring Phoenix public. Analysis of the risk/reward on this shell definitely became more difficult with that decision because it introduced much more uncertainty. It may not be a very popular opinion at the moment, but I still think the risk/reward looks somewhat interesting.
This is the way I am looking at TCRI right now: There are any number of scenarios that might play out here, some extremely good and some extremely bad. Maybe Phoenix decides to let Seng Yeap Kok (the current TCRI CEO, a consultant to TCRI/Phoenix, and the former majority shareholder) find another reverse merger candidate. Or maybe Phoenix with its extensive connections in the business world has other ideas on what it wants to do with the TCRI shell. Depending on how a reverse merger is structured here, TCRI's current legacy share valuation could be under $500K.
As of the last quarterly report, Munaf Ali and Phoenix still owned the majority shares, and they were paying all of the shell's expenses. I checked the LinkedIn profile for the Phoenix CFO (Jeetendra Bhatia) and he still mentions that Phoenix controls a stock in the United States. Phoenix issued a press release last week, and it reinforces the scope/influence of that company's operations. From my perspective it is hard to ignore the involvement of Phoenix in TCRI. Until that involvement significantly changes, I would like to have some exposure to this shell.
https://www.yahoo.com/now/phoenix-technology-eyes-global-expansion-084800622.html
Two low float mergers with promise
$HDUP
$BABL
30 million share day would equal game changer…
$ASKH
It would possibly blow the entire OTC up as it would be the only play of substance "IF"....
Imagine a 30 million share volume day!!!!!
Desperately…$hit is dead.
ASKH…$$$…maybe?
How about the one that a delusional poster keeps on referring to $4.59 or ????????????????????????
Since of course USXP is out of the question
HLTT(.30)...post-merger details on the proposed SPK/Varian deal......
Faster, Faster, the light is turning red...
Yeah when I saw they were looking outside of China was a nice surprise.
That would be way better than Chinese.
Yes - working with CIWM to find one is all we have thus far. Please be Australia or New Zealand based IF.
IF there is a partner.
Hell there’s no doubt lol - but if the partner is quality we may get an offset for his investor relations shortcomings.
CLHI was merging with TDS UK a $1 mil revenue tech outfit with 6 employees. Kudos to those folks driving it to $2.48 as IR mentioned.
ASKH will be all about the partner and thankfully not Richards.
There's one big difference - CLHI had a community of people following it, and, at the time, Synergy actively working the shell.
However, to use either "actively" or working in a sentence with our CEO in ASKH would be an oxymoron.
Followers
|
177
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
6024
|
Created
|
02/02/12
|
Type
|
Free
|
Moderator Involuntary-Recluse | |||
Assistants TURCH puffadder |
Identify and target the following opportunities:
Posts Today
|
0
|
Posts (Total)
|
6024
|
Posters
|
|
Moderator
|
|
Assistants
|
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |